Rossari Biotech is currently trading at Rs. 1299.15, up by 35.35 points or 2.80% from its previous closing of Rs. 1263.80 on the BSE.
The scrip opened at Rs. 1300.00 and has touched a high and low of Rs. 1338.95 and Rs. 1289.10 respectively. So far 18732 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 1347.60 on 10-May-2021 and a 52 week low of Rs. 663.55 on 23-Jul-2020.
Last one week high and low of the scrip stood at Rs. 1338.95 and Rs. 1218.00 respectively. The current market cap of the company is Rs. 6943.50 crore.
The promoters holding in the company stood at 72.69%, while Institutions and Non-Institutions held 19.70% and 7.61% respectively.
Rossari Biotech is planning to acquire 100 percent of the equity capital of Unitop Chemicals, a supplier of surfactants, emulsifiers, and specialty chemicals. The company further stated that 65 percent of the equity share capital will be acquired upon closure of the transaction, and the balance 35 percent over the next two years. The total consideration for the acquisition of a 100 percent equity stake is Rs 421 crore.
This acquisition will bring complementary dimensions to Rossari Biotech and help expand its product portfolio, presence in adjoining areas of specialty chemical segments, pooling together of related technologies, larger international exposure, better domestic market reach, well-experienced and competent talent pool, and increased end-user industry applications.
Rossari Biotech is a specialty chemicals manufacturing firm with focus on home and personal care, performance chemicals, textile specialty chemicals and animal health and nutrition products. Apart from India, it has operations in 17 countries including Vietnam, Bangladesh and Mauritius.
| Company Name | CMP |
|---|---|
| Tata Chemicals | 1057.25 |
| SRF | 2269.55 |
| Pidilite Inds. | 3058.65 |
| Aarti Inds | 421.75 |
| Atul | 7400.00 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Limited to the first 10 users today!
Practical Stock Investing Hand Book
By - Raymond Moses
Founder of MoneyWorks4Me | Consultant | Trainer | Author | TEDx Speaker
Register & Get Instant Access!Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
